Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001415889-23-002757

Options or other derivatives

  • PRESIDENT AND CEO acquired 374,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Zeskind Benjamin J. PRESIDENT AND CEO 2023-02-15 Grant or award · Stock Option +352,244 352,244 D
Zeskind Benjamin J. PRESIDENT AND CEO 2023-02-15 Grant or award · Stock Option +21,756 374,000 D
Loading xslF345X03/form4-02172023_040220.xml…